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Abstract The mechanism of acute nephrotoxicity of an iron 
chelate in vivo has been investigated. Administration of a renal 
carcinogen ferric nitrilotriacetate (Fe-NTA) (15 mg Fe/kg body 
weight, intraperitoneally) led to selective loss of a renal protein 
with an apparent molecular mass of 17 kDa. Analysis of the 
17 kDa protein by NH2-terminal sequence demonstrated its iden- 
tity over 16 NH2-terminal residues as a kidney fatty acid-binding 
protein (k-FABP) that is a proteolytically modified form of a2u- 
globulin, a major urinary protein of adult male rats. An immuno- 
chemical study using anti-a2u-globulin polyclonal antibodies con- 
firmed that a single injection of Fe-NTA led to a decrease in 
k-FABP levels. However, a 19-kDa protein identical to the C~zu- 
globulin progressively appeared in the kidney, suggesting that the 
proteolytic processing of azu-globnlin in the renal proximal tu- 
bules was suppressed by the treatment with Fe-NTA. By monitor- 
ing k-FABP and its precursor Ot2u-globulin , it was determined 
that repeated exposure to Fe-NTA caused suppression of both 
proteolytic and endocytotic activity of the kidney. The implica- 
tions of these data in relation to the nephrotoxicity of Fe-NTA 
are discussed. 
renal carcinogenesis mediated by Fe-NTA treatment, the role 
of iron or Fe-NTA has not been fully established, except for 
the induction of lipid peroxidation. Okada and his co-workers 
have shown that membrane lipid peroxidation, as seen bio- 
chemically by 2-thiobarbituric acid-reactive substances 
(TBARS) and histochemically b cold Schiff's method (detec- 
tion of aldehydes), is one of the basic mechanisms of Fe-NTA- 
induced renal injury and is closely associated with renal carcin- 
ogenesis [10-14]. It can therefore be assumed that these renal 
oxidative injuries are associated with the alteration of the fun- 
damental functions of the kidney, including reabsorption of 
filtered proteins from glomerular ultrafiltrate and their proteol- 
ysis. 
In the present paper, based on the identification of a major 
kidney-specific protein, we demonstrate the alteration of prote- 
olytic and endocytotic functions of the renal brush border 
membrane caused by Fe-NTA treatment. 
2. Materials and methods 
Key words: Ferric nitrilotriacetate; Renal carcinogen; Kidney 
fatty acid-binding protein; ~2v-Globulin 
1. Introduction 
There is a hypothesis that an elevated incidence of cancer is 
associated with chronic iron overload [1]. In fact, the risk for 
primary hepatocellular carcinoma in idiopathic hemochroma- 
tosis is more than 200 times greater than that of the control 
population [2,3]. Awai et al. [4] originally developed an experi- 
mental model of iron overload using ferric ion chelated with 
nitrilotriacetate (NTA). Intraperitoneal injections of Fe-NTA 
induced significant iron deposition in rat hepatic cells [5,6]. 
Repeated intraperitoneal injections of Fe-NTA were reported 
to induce acute and subacute renal proximal tubular necrosis 
and a subsequent high incidence of renal adenocarcinoma in 
male rats and mice [7-9]. Despite the pathological evidence for 
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Abbreviations: Fe-NTA, ferric nitrilotriacetate; k-FABP, kidney fatty 
acid-binding protein; SDS-PAGE, sodium dodecylsulfate-polyacryl- 
amide gel electrophoresis; TBARS, 2-thiobarbiturie acid-reactive sub- 
stances; BSA, bovine serum albumin; ECL, enhanced chemilumines- 
cence; TBS, Tris-buffered saline. 
2.1. Animals and experimental groups 
Male SPF sic: Wistar rats (Shizuoka Laboratory Animal Center, 
Shizuoka), weighing 130 to 150 g (6 weeks of age) were used. They were 
kept in stainless teel cages and given commercial rat chow (Funabashi 
F-2, Cbiba) as well as deionized water (Millipore Japan, Osaka) ad 
libitum. A total of thirty animals were divided into a time-course tudy 
group (Fe-NTA 15 mg Fe/kg body weight; 0, 1, 3, 16, and 24 h), a 
dose-dependency study group (1 h; Fe-NTA 0, 15, and 30 mg Fe/kg 
body weight), and subacute oxicity groups: group A (1 week-treatment: 
5 mg Fe/kg body weight daily for 3 days and 10 mg Fe/kg body weight 
daily for the next 3 days); group B (3 weeks-treatment: 5 mg Fe/kg body 
weight daily for 3 days, 10 mg Fe/kg body weight for the next 3 days, 
one day break, 10 mg Fe/kg body weight for the next 5 days, 2 days 
break, and 10 mg Fe/kg body weight for the next 4 days). Each sub- 
group contained 3 animals. The animals were sacrificed by decapitation 
and both kidneys of each animal were removed immediately. In the case 
of subacute toxicity experiments, he animals were sacrificed 24 h after 
the final injection. 
2.2. Materials 
Ferric nitrate nneahydrate, sodium carbonate, hydrogen peroxide, 
acetone, and ethanol were obtained from Wako (Osaka). Nitrilotri- 
acetic acid disodium salt was obtained from Nacarai Tesque, Inc. 
(Kyoto). Horseradish peroxidase-linked anti-rabbit IgG immunoglob- 
ulin and ECL (enhanced chemiluminescence) W stern blotting detec- 
tion reagents were obtained from Cappel (Durham, NC) and Amer- 
sham, respectively. The protein concentration was measured using the 
BCA protein assay reagent obtained from Pierce. 
2.3. Preparation and injection of Fe-NTA solution 
The Fe-NTA solution was prepared immediately before use by the 
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method of Awai et al. [4] with only a slight modification. Ferric nitrate 
enneahydrate and nitrilotriacetic a id disodium salt were each dissolved 
in deionized water to form 300 mM and 600 mM solutions. They were 
mixed at a volume ratio of 1 : 2 (molar atio 1 : 4) with magnetic stirring 
at room temperature. The pH was adjusted with sodium carbonate to 
7.4. The Fe-NTA was injected intraperitoneally into the animals. 
2.4. Partial pur(fieation q[17 kDa protein and NH,-terminal sequence 
determinations 
The total cytosolic proteins were dialyzed against 20 mM Tris-HCl 
(pH 8.0), and the proteins were then applied to an ion exchange column 
(TSKgel DEAE-5PW) (TOSO). The samples were eluted with a linear 
gradient of 100% solvent A (20 mM Tris-HCI, pH 8.0) to 100% solvent 
B (0.5 M NaCI/20 mM Tris-HCl, pH 8.0) within 30 min at a flow rate 
of 1.0 ml/min. The proteins were monitored at 280 nm. The proteins 
from HPLC were then separated by a sodium dodecylsulfate-poly- 
acrylamide gel electrophoresis (SDS-PAGE) and electroblotted onto a 
polyvinylidene difluoride (PVDF) membrane (Millipore). Automated 
Edman NH2-terminal sequence determinations were performed with an 
Applied Biosystem Gas-phase Sequencer (Models 470/120/900). 
2.5. Antibodies 
Polyclonal antiserum against ~2u-globulin prepared according to the 
method of Ghosh et al. [15] was raised by immunizing New Zealand 
White rabbits with ~2u-globulin in a 50% emulsion with complete 
Freund's adjuvant at a final volume of 0.5 ml. After a booster injection 
over a period of one month, anti-~2wglobulin a tiserum was obtained. 
2.6. Western blot 
Rat kidneys were homogenized with 1.15% KCI (9 ml/g). The kidney 
tissue homogenate ( 1ml) was centrifuged for 10 min at 400 x g and then 
the supernatant was centrifuged for 60 min at 105,000 x g to obtain the 
cytoplasmic fractions, which were then treated with Laemmli sample 
buffer [16] for 3 5 min at 100°C. The samples were run on two 10% 
SDS-PAGE slab gels. One gel was used for staining with Coomassie 
brilliant blue; the other was transblotted to lmmobilon PVDF mem- 
branes, incubated with 2% BSA in TBS/Tween for blocking, washed, 
and treated with the antibody. This procedure was followed by the 
addition of horseradish peroxidase conjugated to goat anti-rabbit IgG 
immunoglobulin and ECL reagents. The bands were visualized by ex- 
posure of the membranes to autoradiography film. 
3. Results and discussion 
As reported previously, a single intraperitoneal injection of 
Fe-NTA (15 mg Fe/kg body weight) leads to membrane dam- 
age assessed by the accumulation of lipid peroxidation-derived 
aldehydes [17]. Upon SDS-PAGE analysis, we found that this 
membrane damage was accompanied by significant alteration 
of the renal cytosolic proteins (Fig. 1). Particularly evident was 
the loss of a protein with apparent molecular mass of 17 kDa. 
In order to identify the 17 kDa protein, proteins from HPLC 
on a DEAE column were separated by SDS-PAGE and elec- 
troblotted onto a PVDF membrane for NHz-terminal sequence 
analysis. Comparison of the 17 kDa protein sequence with the 
data base (GENETYX)  indicated a 100% positive identifica- 
tion, over 16 residues, with the NH 2 terminus of the kidney fatty 
acid-binding protein (k-FABP) as follows: 
NHz-L-D-V-A-K-L-N-G-D-W-F-S-I-V-V-A-. 
It is known that k-FABP, a proteolytically modified form of 
a2u-globulin, is reabsorbed by endocytosis in the renal proxi- 
mal tubules, is predominantly localized in the endosomes or 
lysosomes and is also associated with brush border membranes 
[18]. Whereas, a2u-globulin is a secretory 18.7 kDa protein 
synthesized in the liver [19,20] and reabsorbed by a mechanism 
that includes the interaction of cationic groups with the mole- 
cule with anionic sites on the brush border membranes of the 
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Fig. I. Time-dependent changes in renal cytosolic proteins of rats 
treated with Fe-NTA (15 mg Fe per kg body weight). The arrow 
indicates a 17 kDa protein. 
renal proximal tubules. It has been suggested that, during the 
time that ~2u-globulin is taken up from the urinary lumen into 
the endosomes, ~2u-globulin is proteolytically processed in the 
amino- and carboxyl-terminal regions and then converted to 
k-FABP by the protease associated with the brush border mem- 
brane. These facts lead to the assumption that the proteolytic 
conversion of C~2u-globulin to k-FABP followed by its endocy- 
tosis is an available index of structural and functional altera- 
tions of the brush border membrane of the renal proximal 
tubules caused by Fe-NTA. 
It has been proposed that Fe-NTA can be easily activated by 
reducing agents including cysteine and y-glutamylcysteine. 
These reducing agents are amply supplied by the decomposition 
of glutathione within the lumen by the action of y-glutam- 
yltranspeptidase and dipeptidase situated at the proximal tubu- 
lar brush border membrane, thereby effectively promoted the 
membrane lipid peroxidation [12,21,22]. To determine the effect 
of Fe-NTA on the proteolytic and endocytotic functions of the 
kidney monitoring with k-FABP and ~2v-globulin as markers, 
rabbit polyclonal IgG against CX2u-globulin was raised and used 
for the immunochemical nalysis of these proteins. In the con- 
trol rats, an immunoblot analysis of the renal cytosolic proteins 
revealed that only a single protein band representing k-FABP 
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Fig. 2. Western blot analysis of k-FABP and ~2u-globulin  the renal 
cytosolic fraction of rats treated with Fe-NTA. (A) A time course study 
with a single injection of Fe-NTA (15 mg of Fe per kg body weight). 
(B) A subacute toxicity experiments with multiple injections of 
Fe-NTA. Lane 1, control; lane 2, group A (l-week treatment: 5 mg 
Fe/kg body weight daily for 3 days and 10 mg Fe/kg body weight daily 
for the next 3 days); lane 3, group B (3-week treatment: 5 mg Fe/kg body 
weight daily for 3 days, 10 mg Fe/kg body weight for the next 3 days, 
one day break, 10 mg Fe/kg body weight for the next 5 days, 2 days 
break, and 10 mg Fe/kg body weight for the next 4 days). Cytosolic 
proteins were isolated from the rat kidney and analyzed by Western blot 
using anti-CZ2u-globulin antibody. 
showed an apparent immunoreactivity with the anti-~2u-globu- 
lin antibodies (Fig. 2A). A single injection of Fe-NTA (15 mg 
Fe/kg body weight) resulted in the time-dependent appearance 
of ~2u-globulin, accompanied by a decrease in k-FABE These 
observations suggest hat the endocytotic activity of proximal 
tubules in the reabsorption of a filtered protein (otto-globulin) 
from the glomerular ultrafiltrate was not altered; however, the 
proteolytic activity was progressively suppressed by treatment 
with Fe-NTA. It was observed that the suppression of prote- 
olytic conversion of ~2u-globulin to k-FABP was clearly de- 
pendent upon the period of time after Fe-NTA treatment, be- 
cause little or no suppression was observed for a period up to 
an hour; however, the suppression of the conversion started 3 h 
after Fe-NTA treatment (Fig. 2A). This and the fact that the 
renal membrane damage reached the maximum within an hour 
after Fe-NTA treatment (15 mg Fe/kg body weight) [17] suggest 
that the proteases in the renal brush border membranes were 
inactivated or depleted by an Fe-NTA-induced membrane lipid 
peroxidation. These renal proximal tubular dysfunctions 
caused by Fe-NTA treatment are consistent with the fact [23] 
that the injection of Fe-NTA causes a number of time-depend- 
ent morphological terations in the structure of the renal prox- 
imal tubules including the loss of the brush border from the 
apical membrane of the epithelium at an early stage of injury. 
Furthermore, it should be noted that, although a single dose 
of Fe-NTA altered only the proteolytic activity of proximal 
tubular cells (Fig. 2A), multiple injections of Fe-NTA led to the 
suppression of both proteolytic and endocytotic activities of the 
kidney (Fig. 2B, lanes 2 and 3). The ct2u-globulin/k-FABP may 
play an important role in the transport and metabolism of fatty 
acids in the rat kidney. Thus, the inhibition of reabsorption of 
the filtered proteins may implicate severe damage of the prox- 
imal tubular epithelium, eventually leading to renal carcino- 
genesis. 
Disturbances of the proximal tubular function are often ob- 
served in a lot of clinical situations. They may be caused by 
nephrotoxic agents uch as certain antibiotics and chemother- 
apeutic drugs and by hypotension and/or ischemia. These con- 
ditions are often associated with membrane lipid peroxidation. 
Therefore, monitoring the proteolytic onversion of ~2v-globu- 
lin to k-FABP followed by its endocytosis may be useful to 
identify the chemicals that cause membrane damage in the rat 
kidney. 
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